Abstract

BackgroundLeprosy continues to be a public health problem in many countries. Difficulties faced by health services include late diagnosis, under-reporting of new cases, adequate monitoring of disabilities and treatment. Furthermore, systematic follow-up after completion of treatment is important, when new disabilities may occur, or existing disabilities may get worse. The objective of the present study was to determine the prevalence of leprosy-associated grade 2 disabilities (G2D) after completion of multidrug therapy (MDT) and to identify factors associated with G2D.MethodsWe performed a cross-sectional study of 222 leprosy cases registered in Vitória da Conquista, Bahia state, Brazil from 2001–2014. We performed a clinical examination of the study participants and collected socio-economic and clinical information by interview. We identified factors associated with grade 2 disability (G2D) using logis tic regression.ResultsIn total, 38 (17.1%) participants were diagnosed with G2D, and 106 (47.7%) with grade 1 disabilities (G1D). The following independent factors were significantly associated with G2D: occurrence of leprosy reaction (adjusted OR = 2.5; 95%CI = 1.09–5.77), thickening and/or tenderness of one or more nerve trunks (adjusted OR = 3.0; CI = 1.13–8.01) and unemployment (adjusted OR = 7.17; CI = 2.44–21.07).ConclusionsThis study shows that physical disabilities remain after completion of MDT and frequently occur in an endemic area in Brazil. Finding new ways to reduce the burden of disability are urgently needed, and may include systematic follow-up of patients after treatment completion combined with evidence-based preventative measures.

Highlights

  • In 2016, a total of 214,783 leprosy cases were reported globally, of which 11.7% (25,218) occured in Brazil [1] [2]

  • 38 (17.1%) participants were diagnosed with grade 2 disabilities (G2D), and 106 (47.7%) with grade 1 disabilities (G1D)

  • The following independent factors were significantly associated with G2D: occurrence of leprosy reaction, thickening and/or tenderness of one or more nerve trunks and unemployment

Read more

Summary

Introduction

In 2016, a total of 214,783 leprosy cases were reported globally (case detection rate: 2.9/100,000 population), of which 11.7% (25,218) occured in Brazil [1] (case detection rate: 12.2/100,000 population) [2]. The nerve damage caused by the disease can be sensory, motor and/or autonomic and may occur before diagnosis, during multidrug therapy (MDT) or after completion of treatment [6,7,8,9]. Difficulties faced by health services include late diagnosis, under-reporting of new cases, adequate monitoring of disabilities and treatment. The objective of the present study was to determine the prevalence of leprosy-associated grade 2 disabilities (G2D) after completion of multidrug therapy (MDT) and to identify factors associated with G2D

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call